Research Insights Archive

Home » Research & Resources » Research Insights »Research Insights Archive

November 25, 2019 – Anticholinergic properties and cognition, relevancy to individuals with Parkinson’s Disease (PD)

Medications with anticholinergic activity are used in 8-37 % of older adults to treat various medical conditions that involve contraction and relaxation of muscles, such as PD and overactive bladder, as well as other conditions including seasonal aller …


September 24, 2019 – Impulse Control Disorders in Parkinson’s Disease: A 20-year Odyssey

Citation: Weintraub, D. (2019). Impulse control disorders in Parkinson’s disease: A 20‐year odyssey. Movement Disorders. Impulse Control Disorders (ICDs) are behavioral problems resulting from a person’s difficulty with or inability to resist the drive …


July 22, 2019 – Subthalamic Stimulation, Apomorphine, and Levodopa Infusion in Parkinson’s Disease

Citation: Dafsari, H. S., Martinez‐Martin, P., Rizos, A., Trost, M., dos Santos Ghilardi, M. G., Reddy, P., & Barbe, M. T. (2019). EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson’s disease. Movement Disorders, s3 …


May 22, 2019 – Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimize Quality of Life

Citation: Daneault, J., Vergara-Diaz, G. & Lee, S. I. (2016). Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimise Quality of Life. European Medical Journal, 1, 62-69. Intr …


March 22, 2019 – Profile of Inhaled Levodopa and its Potential in the Treatment of Parkinson’s Disease: Evidence to Date

Citation: Patel, A. B., & Jimenez-Shahed, J. (2018). Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date. Neuropsychiatric disease and treatment, 14, 2955. Introduction: Levodopa has been the gold …


January 21, 2019 – Predictors to Quality of life improvements after subthalamic stimulation in Parkinson’s Disease

Citation: Liu, F. T., Lang, L. Q., Yang, Y. J., Zhao, J., Feng, R., Hu, J., … & Wu, J. J. (2018). Predictors to quality‐of‐life improvements after subthalamic stimulation in Parkinson’s disease. Acta Neurologica Scandinavica.  Introduction: Subth …


Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2022 The Parkinson Alliance. All rights reserved.